Omega Fund Management as of Dec. 31, 2023
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lexeo Therapeutics Common Stock (LXEO) | 23.5 | $29M | 2.2M | 13.42 | |
| Replimune Group Common Stock (REPL) | 20.5 | $25M | 3.0M | 8.43 | |
| Nuvation Bio Common Stock Class A (NUVB) | 18.4 | $23M | 15M | 1.51 | |
| enGene Holdings Common Stock (ENGN) | 8.5 | $10M | 1.1M | 9.23 | |
| Morphic Holding Common Stock (MORF) | 7.2 | $8.9M | 310k | 28.88 | |
| Spruce Biosciences Common Stock (SPRB) | 5.1 | $6.3M | 2.2M | 2.93 | |
| Kronos Bio Common Stock (KRON) | 3.9 | $4.8M | 3.8M | 1.25 | |
| Ikena Oncology Common Stock (IKNA) | 3.6 | $4.4M | 2.2M | 1.97 | |
| Sana Biotechnology Common Stock (SANA) | 2.8 | $3.4M | 844k | 4.08 | |
| Theseus Pharmaceuticals Common Stock | 2.3 | $2.9M | 712k | 4.05 | |
| Immunic Common Stock (IMUX) | 2.2 | $2.7M | 1.8M | 1.50 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 1.6 | $2.0M | 251k | 7.79 | |
| enGene Holdings Warrant (ENGNW) | 0.3 | $404k | 475k | 0.85 | |
| Senti Biosciences Common Stock (SNTI) | 0.1 | $129k | 196k | 0.66 |
